InvestorsHub Logo
Followers 407
Posts 43314
Boards Moderated 0
Alias Born 08/24/2005

Re: FELLER post# 44341

Tuesday, 01/31/2017 6:35:19 PM

Tuesday, January 31, 2017 6:35:19 PM

Post# of 203913
GWPH is spitting distance from FDA approval for i think sativex, an epilepsy drug that might also be able to be prescribed more widely? THAT is why they are given that valuation. BUT once the door is open, w FDA approving MMJ, OWC's products will have much easier regulatory passage, and they are advancing on multiple disease fronts already.

AXIM imo is a much closer comparable, as they are also OTCQB and a similar premarket MMJ pharma.